Related Experiment Videos
Gene therapy for retinal and choroidal diseases
1Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287-9277, USA. pcampo@jhmi.edu
Expert Opinion on Biological Therapy
|June 25, 2002
Summary
Gene therapy offers a promising new treatment for retinal and choroidal diseases by delivering therapeutic genes directly to the eye. This approach shows potential for restoring vision and treating conditions like Leber's Congenital Amaurosis.
Area of Science:
- Ophthalmology
- Genetics
- Molecular Biology
Background:
- The eye's unique structure, separated by blood-ocular barriers, is advantageous for targeted gene therapy.
- Retinal and choroidal diseases often stem from genetic mutations affecting photoreceptor or retinal pigmented epithelial (RPE) cells.
Purpose of the Study:
- To review the progress and potential of intraocular gene transfer for treating retinal and choroidal diseases.
- To highlight gene replacement strategies for inherited retinal degenerations and novel approaches for neovascularization.
Main Methods:
- Adeno-associated viral vectors (AAVs) for gene delivery.
- Gene therapy utilizing ribozymes and survival factors.
- Transduction of ocular cells with antiangiogenic protein-encoding constructs.
Main Results:
- Successful restoration of visual function in RPE65 (-/-) dogs using AAV vectors encoding RPE65.
- Demonstrated proof of principle for gene therapy in dominant inherited retinal degenerations.
- Emerging strategies for neovascular diseases through antiangiogenic gene transfer.
Conclusions:
- Intraocular gene therapy is a rapidly advancing field with significant potential for treating a range of retinal and choroidal diseases.
- Clinical applications are on the horizon, offering new therapeutic options beyond current treatments.
- Further research is needed to optimize delivery and efficacy for widespread clinical use.